These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36713812)
21. SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC. Hasmim M; Xiao M; Van Moer K; Kumar A; Oniga A; Mittelbronn M; Duhem C; Chammout A; Berchem G; Thiery JP; Volpert M; Hollier B; Noman MZ; Janji B Front Immunol; 2022; 13():982821. PubMed ID: 36159844 [TBL] [Abstract][Full Text] [Related]
22. DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-Myb acetylation upon matrix stiffening. Kim D; You E; Jeong J; Ko P; Kim JW; Rhee S Sci Rep; 2017 Jul; 7(1):6847. PubMed ID: 28754957 [TBL] [Abstract][Full Text] [Related]
23. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells. Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526 [TBL] [Abstract][Full Text] [Related]
24. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. Moes M; Le Béchec A; Crespo I; Laurini C; Halavatyi A; Vetter G; Del Sol A; Friederich E PLoS One; 2012; 7(4):e35440. PubMed ID: 22514743 [TBL] [Abstract][Full Text] [Related]
25. MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1. Xiang XJ; Deng J; Liu YW; Wan LY; Feng M; Chen J; Xiong JP Cell Physiol Biochem; 2015; 36(4):1382-94. PubMed ID: 26159618 [TBL] [Abstract][Full Text] [Related]
26. Loss of SNAI1 induces cellular plasticity in invasive triple-negative breast cancer cells. Tsirigoti C; Ali MM; Maturi V; Heldin CH; Moustakas A Cell Death Dis; 2022 Sep; 13(9):832. PubMed ID: 36171192 [TBL] [Abstract][Full Text] [Related]
29. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101 [TBL] [Abstract][Full Text] [Related]
30. Mesenchymal-epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate. Terragno M; Vetrova A; Semenov O; Sayan AE; Kriajevska M; Tulchinsky E Sci Rep; 2024 Jan; 14(1):425. PubMed ID: 38172210 [TBL] [Abstract][Full Text] [Related]
32. The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas. Gao M; Shih IeM; Wang TL Int J Mol Sci; 2012 Oct; 13(11):13881-93. PubMed ID: 23203039 [TBL] [Abstract][Full Text] [Related]
33. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC. Kong P; Xu E; Bi Y; Xu X; Liu X; Song B; Zhang L; Cheng C; Yan T; Qian Y; Yang J; Ma Y; Cui H; Zhai Y; Zou B; Liu X; Cheng Y; Guo S; Cheng X; Cui Y Theranostics; 2020; 10(4):1798-1813. PubMed ID: 32042337 [No Abstract] [Full Text] [Related]
34. Revolutionary multi-omics analysis revealing prognostic signature of thyroid cancer and subsequent in vitro validation of SNAI1 in mediating thyroid cancer progression through EMT. Jin X; Fu C; Qi J; Chen C Clin Exp Med; 2024 Jun; 24(1):127. PubMed ID: 38869635 [TBL] [Abstract][Full Text] [Related]
35. miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer. Liu Z; Long J; Du R; Ge C; Guo K; Xu Y Tumour Biol; 2016 Jun; 37(6):8327-35. PubMed ID: 26729198 [TBL] [Abstract][Full Text] [Related]
36. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway. Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506 [TBL] [Abstract][Full Text] [Related]
37. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA. Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266 [TBL] [Abstract][Full Text] [Related]
38. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer. Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337 [TBL] [Abstract][Full Text] [Related]
39. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. Walsh LA; Nawshad A; Medici D Matrix Biol; 2011 May; 30(4):243-7. PubMed ID: 21477649 [TBL] [Abstract][Full Text] [Related]
40. FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1. Wang S; Yan S; Zhu S; Zhao Y; Yan J; Xiao Z; Bi J; Qiu J; Zhang D; Hong Z; Zhang L; Huang C; Li T; Liang L; Liao W; Jiao H; Ding Y; Ye Y Neoplasia; 2018 Oct; 20(10):996-1007. PubMed ID: 30189360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]